Szarkóma: vizsgálatok itt: Németország
32 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleSTART: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
- Where
- Berlin, Frankfurt am Main, Goettingen, Heidelberg, Tübingen
- Életkor
- 18 év and over
- People
- 15 worldwide
- Run by
- Valo Therapeutics Oy
See details and how to joinNCT05492682 · EU 2024-517580-23-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- Berlin, Bielefeld, Essen, Esslingen am Neckar, Gauting, Homburg, Offenbach Am Main, Oldenburg, Regensburg, Stuttgart, Wuerzburg
- Életkor
- 18 év and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01 - 1. fázisNot yet taking people in NémetországGD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid Tumors
- Where
- Münster
- Életkor
- 1 év to 25 év
- People
- 30
- Run by
- Universität Münster
See details and how to joinNCT07897968 - 1. fázisTaking peopleInternational Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing Sarkoma
- Where
- Berlin, Essen, Göttingen, Greifswald, Mainz
- Életkor
- 12 hónap and over
- People
- 18
- Run by
- Prof. Dr. Dr. Birgit Burkhardt
See details and how to joinNCT06839703 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Berlin, Cologne, Giessen, Muenster, Tuebingen
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 3. fázisTaking peopleA Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Where
- Bielefeld, Greifswald, Solingen, Stuttgart
- Életkor
- 18 év and over
- People
- 348 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00 - 3. fázisTaking peopleInternational Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- Where
- Aachen, Augsburg, Bad Saarow, Berlin, Bielefeld, Bonn, Bremen, Brunswick, Chemnitz, Cologne, Cottbus, Datteln, Dortmund, Dresden, Duesseldorf, Erfurt, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Giessen, Gießen, Goettingen, Greifswald, Halle Saale, Hamburg, Hanover, Heidelberg, Herdecke, Homburg, Jena, Karlsruhe, Kassel, Kiel, Koblenz, Krefeld, Leipzig, Lübeck, Magdeburg, Mainz, Mannheim, Minden, Muenster, München, Munich, Nuremberg, Nürnberg, Oldenburg, Regensburg, Rostock, Sankt Augustin, Schwerin, Stuttgart, Tuebingen, Ulm, Wuerzburg
- Életkor
- Up to 64 év
- People
- 1351 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501180-40-00 · EU 2022-501180-40-00 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Essen
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631 - 3. fázisTaking peopleSurgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Where
- Dresden, Goettigen, Mannheim
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04031677 - 1. fázisTaking peopleLong-term follow-up of patients treated with GD2IL18CART
- Where
- Erlangen, Essen, Muenster, Tuebingen
- People
- 20
- Run by
- Universitaet Muenster
See details and how to join2025-521497-34-00 · EU 2025-521497-34-00 - 1. fázisTaking peopleA phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-DFC413 and safety and imaging properties of [68Ga]Ga-NNS309 in patients with solid tumors
- Where
- Essen
- Életkor
- 18 év and over
- People
- 62 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521702-18-00 · EU 2025-521702-18-00 - 1/2. fázisTaking peopleFirst-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
- Where
- Essen
- Életkor
- 18 év and over
- People
- 270 worldwide
- Run by
- Adcendo ApS
See details and how to joinNCT06797999 · EU 2024-516900-41-00 - 1. fázisTaking peopleA phase I safety, dose finding and feasibility trial of GD2IL18CART in patients with relapsed or refractory GD2 positive solid cancers
- Where
- Erlangen, Essen, Muenster, Tuebingen
- People
- 48
- Run by
- Universitaet Muenster
See details and how to join2022-501725-21-00 · EU 2022-501725-21-00 - 3. fázisTaking peopleA Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
- Where
- Bad Saarow, Hanover, Leipzig
- Életkor
- 18 év and over
- People
- 333 worldwide
- Run by
- Intensity Therapeutics, Inc.
See details and how to joinNCT06263231 · EU 2024-512423-36-00 - No phaseTaking peopleColorectal Resections in Patients With Retroperitoneal Sarcoma
- Where
- Berlin, Cologne, Dresden, Erlangen, Göttingen, Greifswald, Halle, Hamburg, Hanover, Heidelberg, Magdeburg, Mannheim, München, Tübingen, Ulm
- Életkor
- 18 év and over
- People
- 120 worldwide
- Run by
- Heidelberg University
See details and how to joinNCT06943612 - 1. fázisTaking peopleInternational open-label phase I dose escalation study of dinutuximab beta in combination with vincristine/doxorubicin/cyclophosphamide and ifosfamide/etoposide in pediatric, adolescent, and adult patients with GD2-positive Ewing sarcoma
- Where
- Berlin, Erlangen, Essen, Frankfurt Am Main, Freiburg im Breisgau, Goettingen, Greifswald, Hamburg, Heidelberg, Leipzig, Mainz
- People
- 18 worldwide
- Run by
- GPOH gGmbH
See details and how to join2024-515245-42-00 · EU 2024-515245-42-00 - 1/2. fázisTaking peopleMaster Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC
- Where
- Berlin, Dresden, Heidelberg, Leipzig, München, Tübingen
- Életkor
- 18 év and over
- People
- 96 worldwide
- Run by
- Anocca AB
See details and how to joinNCT07145450 - 1/2. fázisTaking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Dresden, Heidelberg
- Életkor
- 12 év and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - 1/2. fázisTaking peoplePersonalized Vaccination in Fusion+ Sarcoma Patients (PerVision)
- Where
- Berlin, Dresden, Essen, Frankfurt Am Main, Freiburg, Munich, Tuebingen
- Életkor
- 2 év to 40 év
- People
- 30
- Run by
- University Hospital Tuebingen
See details and how to joinNCT06094101 · EU 2024-511337-35-00 - No phaseTaking peopleThe Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
- Where
- Essen, München
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT06408441 - No phaseTaking peopleNeoadjuvant Irradiation of Retroperitoneal Soft Tissue Sarcoma With Ions Retro-Ion
- Where
- Heidelberg
- Életkor
- 18 év and over
- People
- 64
- Run by
- University Hospital Heidelberg
See details and how to joinNCT04219202 - No phaseTaking peopleGISAR German Interdisciplinary Sarcoma Registry
- Where
- Bad Saarow, Berlin, Berlin-Spandau, Erlangen, Frankfurt, Freiburg im Breisgau, Göttingen, Greifswald, Halle, Hamburg, Leipzig, Mainz, Mannheim, Münster, Nuremberg, Regensburg, Tübingen, Würzburg
- Életkor
- 18 év and over
- People
- 9000
- Run by
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
See details and how to joinNCT04122872 - No phaseTaking peopleQuality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)
- Where
- Dresden, Essen, Heidelberg, Mannheim, Wölfersheim
- Életkor
- 18 év and over
- People
- 1600
- Run by
- Technische Universität Dresden
See details and how to joinNCT07148193 - 1. fázisTaking peopleFIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer
- Where
- Tübingen
- Életkor
- 18 év and over
- People
- 89
- Run by
- German Cancer Research Center
See details and how to joinNCT05999396 - 3. fázisTaking peopletTF-NGR Randomized Study - STS
- Where
- Augsburg, Bad Saarow, Berlin, Dresden, Frankfurt Am Main, Hamburg, Hanover, Heidelberg, Jena, Leipzig, Mainz, Muenster, Munich
- Életkor
- 18 év to 75 év
- People
- 126
- Run by
- Universität Münster
See details and how to joinNCT05597917 · EU 2024-516392-33-00